MoneyWorks4Me

Orchid Pharma - Quaterly Results

14 Nov 2021 Evaluate
The September 2021 quarter revenue stood at Rs. 1219.08 millions, up 12.31% as compared to Rs. 1085.50 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2021 is Rs. -207.43 millions as compared to Net Loss of Rs. -249.59 millions of corresponding quarter ended September 2020Operating profit for the quarter ended September 2021 decreased to 92.12 millions as compared to 183.13 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1219.08 1085.50 12.31 2174.45 2275.71 -4.45 4506.95 4812.09 -6.34
Other Income 17.67 9.32 89.59 48.90 22.03 121.97 64.75 242.77 -73.33
PBIDT 92.12 183.13 -49.70 167.81 419.12 -59.96 643.62 336.08 91.51
Interest 98.93 133.31 -25.79 207.72 269.16 -22.83 513.36 41.59 1134.34
PBDT -6.81 49.82 -113.67 -39.91 149.96 -126.61 130.26 294.49 -55.77
Depreciation 200.62 299.41 -32.99 401.70 595.84 -32.58 1088.99 1179.07 -7.64
PBT -207.43 -249.59 -16.89 -441.61 -445.88 -0.96 -958.73 -884.58 8.38
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -207.43 -249.59 -16.89 -441.61 -445.88 -0.96 -958.73 -884.58 8.38
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 7.56 16.87 -55.21 7.72 18.42 -58.10 14.28 6.98 104.47
Peers
Company Name CMP
Sun Pharma. Inds. 1847.95
Dr. Reddys Labs. 1149.30
Cipla 1360.50
Lupin 2046.50
Zydus Lifesciences 1108.45
View more..